. home.aspx



Trifecta Pharmaceuticals USA and Walmart launch distribution partnership

April 08, 2019 / Trifecta Pharmaceuticals

FORT LAUDERDALE, FL, UNITED STATES, April 8, 2019 /EINPresswire.com/ -- TRIFECTAPHARMACEUTICALS USA, a leading developer, manufacturer and distributor of specialty OTC topical ointments, creams and gels, today announces its inaugural distribution partnership with Walmart. Mayinglong hemorrhoid ointment, a known and trusted treatment for the pain and discomfort associated with hemorrhoids, will be available on Walmart’s shelves from April 2019. Mayinglong hemorrhoid ointment combines popular compounds used in Traditional Chinese Medicine with an easy-to-apply formulation. Trifecta Pharmaceuticals USA Chief Executive, Mr. Gregory Brondou, said, “We are delighted to partner with Walmart to bring Mayinglong hemorrhoid ointment, a safe, effective hemorrhoid treatment, to consumers across the United States. Around 15 million Americans are currently experiencing hemorrhoid symptoms, and we’re proud to bring this FDA registered treatment to Walmart’s customers.”